SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-12-006038
Filing Date
2012-11-14
Accepted
2012-11-14 08:02:26
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-Q a50472836.htm 10-Q 757631
2 EXHIBIT 31.1 a50472836ex31_1.htm EX-31.1 15381
3 EXHIBIT 31.2 a50472836ex31_2.htm EX-31.2 14984
4 EXHIBIT 32.1 a50472836ex32_1.htm EX-32.1 6592
5 EXHIBIT 32.2 a50472836ex32_2.htm EX-32.2 6540
6 LOGO logo.jpg GRAPHIC 5318
  Complete submission text file 0001157523-12-006038.txt   3875131

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT opxa-20120930.xml EX-101.INS 368346
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opxa-20120930.xsd EX-101.SCH 44489
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opxa-20120930_cal.xml EX-101.CAL 40604
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opxa-20120930_def.xml EX-101.DEF 229491
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opxa-20120930_lab.xml EX-101.LAB 354132
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opxa-20120930_pre.xml EX-101.PRE 264730
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 121201036
SIC: 2834 Pharmaceutical Preparations